Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer

Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression

(2015) Joan C Delto et al.   Oncotarget

Use of Yeast Chemigenomics and COXEN Informatics in Preclinical Evaluation of Anticancer Agents

(2015) Steven C. Smith et al.   NEOPLASIA

Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer

(2013) K. M. Gust et al.   MOLECULAR CANCER THERAPEUTICS

Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non–muscle invasive bladder cancer

(2013) Andrew J. Lightfoot et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study

(2012) Renzo Colombo et al.   EUROPEAN UROLOGY

Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

(2012) Jorg Oddens et al.   EUROPEAN UROLOGY

Small heat shock proteins in cancer therapy and prognosis

(2012) Amina Zoubeidi et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance

(2012) J. Stuart Ferriss et al.   PLoS One

A Systematic Evaluation of Multi-Gene Predictors for the Pathological Response of Breast Cancer Patients to Chemotherapy

(2012) Kui Shen et al.   PLoS One

Engagement of Integrinβ1 Induces Resistance of Bladder Cancer Cells to Mitomycin-C

(2012) Cheng-Jing Zhang et al.   UROLOGY

The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review

(2011) Rianne J.M. Lammers et al.   EUROPEAN UROLOGY

Potentiation of Mitomycin C Tumoricidal Activity for Transitional Cell Carcinoma by Histone Deacetylase Inhibitors In Vitro

(2011) Abdalla Ali Deb et al.   JOURNAL OF UROLOGY

Urinary pH Is Highly Associated With Tumor Recurrence During Intravesical Mitomycin C Therapy for Nonmuscle Invasive Bladder Tumor

(2011) Takahiro Maeda et al.   JOURNAL OF UROLOGY

Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial

(2011) Savino M Di Stasi et al.   LANCET ONCOLOGY

Small interfering RNA targeting heat shock protein 70 enhances chemosensitivity in human bladder cancer cells

(2011) Hosny M. Behnsawy et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC)

(2010) Renzo Colombo et al.   BJU INTERNATIONAL

Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo

(2010) F R Lamont et al.   BRITISH JOURNAL OF CANCER

The COXEN Principle: Translating Signatures of In vitro Chemosensitivity into Tools for Clinical Outcome Prediction and Drug Discovery in Cancer

(2010) S. C. Smith et al.   CANCER RESEARCH

Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)

(2010) Willem Oosterlinck et al.   EUROPEAN UROLOGY

A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer

(2010) Chung-Hsin Chen et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer

(2009) Paola Gazzaniga et al.   BJU INTERNATIONAL

Cell adhesion to fibronectin induces mitomycin C resistance in bladder cancer cells

(2009) Chun-Wu Pan et al.   BJU INTERNATIONAL

Is Intravesical Bacillus Calmette-Guérin Better than Mitomycin for Intermediate-Risk Bladder Cancer?

(2009) Guido Dalbagni   EUROPEAN UROLOGY

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

(2009) Per-Uno Malmström et al.   EUROPEAN UROLOGY

Converging concepts of protein folding in vitro and in vivo

(2009) F Ulrich Hartl et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer

(2009) Benjamin N. Breyer et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer

(2008) Boris A. Hadaschik et al.   BJU INTERNATIONAL